Novartis AG ADR [NVS] stock prices are down -2.29% to $96.83 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NVS shares have lost -2.36% over the last week, with a monthly amount drifted -6.03%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on December 04, 2024, when HSBC Securities downgraded its rating to a Reduce. Previously, BofA Securities downgraded its rating to Neutral on September 11, 2024, and dropped its price target to $130. On September 05, 2024, downgrade downgraded it’s rating to Neutral. Jefferies downgraded its rating to a Hold. Deutsche Bank downgraded its rating to a Hold. Goldman started tracking with a Buy rating for this stock on May 30, 2024, and assigned it a price target of $120. In a note dated February 23, 2024, BMO Capital Markets initiated an Market Perform rating and provided a target price of $114 on this stock.
The stock price of Novartis AG ADR [NVS] has been fluctuating between $92.35 and $120.92 over the past year. Currently, Wall Street analysts expect the stock to reach $120.5 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $96.83 at the most recent close of the market. An investor can expect a potential return of 24.44% based on the average NVS price forecast.
Analyzing the NVS fundamentals
The Novartis AG ADR [NYSE:NVS] reported sales of 48.59B for trailing twelve months, representing a surge of 8.84%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.25%, and Net Profit Margin reading is 0.35%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.41 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 96.15 points at the first support level, and at 95.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 98.18, and for the 2nd resistance point, it is at 99.53.
Ratios To Look Out For
It’s worth pointing out that Novartis AG ADR [NYSE:NVS]’s Current Ratio is 1.11. In addition, the Quick Ratio stands at 0.90 and the Cash Ratio stands at 0.48. Considering the valuation of this stock, the price to sales ratio is 3.90, the price to book ratio is 4.47 and price to earnings (TTM) ratio is 11.29.
Transactions by insiders
Recent insider trading involved Kowalski Robert William, Officer, that happened on Aug 12 ’24 when 6566.0 shares were purchased.
